BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2245721)

  • 1. Primary non-Hodgkin's lymphoma of the larynx treated only by chemotherapy.
    Blatsios V; Bouros D; Emmanouel A; Niotis M
    Chest; 1990 Dec; 98(6):1547. PubMed ID: 2245721
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Polverino W; Muto P; Zarrilli D
    Haematologica; 1988; 73(6):509-12. PubMed ID: 3148514
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
    Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y
    Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of two multi-drug chemotherapy regimens based on mitoxantrone and epirubicin in 44 patients with non-Hodgkin's lymphoma].
    Gao HR
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):287-90. PubMed ID: 1806350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
    Rolski J; Koralewski P; Pawlicki M
    Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.
    Vorobiof DA; Terblanche AP; Falkson CI; Falkson G
    Oncology; 1988; 45(5):378-9. PubMed ID: 3412747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
    Veneri D; Zanetti F; Franchini M; Krampera M; Pizzolo G
    Haematologica; 2002 Nov; 87(11):ELT43. PubMed ID: 12414364
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
    Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
    Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-Hodgkin's lymphoma of the uterine cervix].
    Plewicka M; Szelc S; Smok-Ragankiewicz A; Wojcieszek A; Szkita D
    Ginekol Pol; 1995 Apr; 66(4):246-8. PubMed ID: 8529943
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma.
    Kim JG; Sohn SK; Kim DH; Baek JH; Park TI; Lee KB
    J Korean Med Sci; 2004 Dec; 19(6):820-5. PubMed ID: 15608392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ga-67 imaging in the diagnosis and management of primary non-Hodgkin's lymphoma of the larynx.
    Khoury J; Jerushalmi J; Cohen HI; Nasrallah S
    Clin Nucl Med; 2002 Jan; 27(1):63-4. PubMed ID: 11805494
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myocardial infarction in man treated with epirubicin for non-Hodgkin lymphoma.
    Aydiner A; Buğra Z; Topuz E; Meriç M
    Am J Clin Oncol; 1995 Oct; 18(5):444-8. PubMed ID: 7572766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
    Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
    Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
    Michiels JJ
    Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology].
    Tominaga S; Kondo M
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolated primary non-Hodgkin's malignant lymphoma of the larynx.
    Cavalot AL; Preti G; Vione N; Nazionale G; Palonta F; Fadda GL
    J Laryngol Otol; 2001 Apr; 115(4):324-6. PubMed ID: 11276342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Salloum E; Levin M
    N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.